Cleared Traditional

K131493 - SIDEKICK AND USHER SUPPORT CATHETERS

K131493 is the FDA 510(k) clearance for SIDEKICK AND USHER SUPPORT CATHETERS by C.R. Bard, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K131493 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
71d
Days
Class 2
Risk

K131493 is an FDA 510(k) clearance for the SIDEKICK AND USHER SUPPORT CATHETERS. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Tempe, US). The FDA issued a Cleared decision on August 2, 2013 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K131493 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2013
Decision Date August 02, 2013
Days to Decision 71 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQY Catheter, Percutaneous

All 482
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K131493.
CONCIERGE GUIDING CATHETER
K132409 · Merit Medical Systems, Inc. · Aug 2013
SELECTRA ACCESSORY KIT, SELECTRA SLITTER TOOL
K131978 · Biotronik, Inc. · Aug 2013
AMPLATZER TORQ VUE LP DELIVERY SYSTEM
K131063 · St Jude Medical · Aug 2013
CODA BALLOON CATHETER
K122917 · Cook, Inc. · Jun 2013
CPS AIM UNIVERSAL SLITTABLE INNER CATHETER
K130252 · St Jude Medical · Mar 2013
CPS DIRECT UNIVERSAL SLITTABLE OUTER CATHETER
K130257 · St Jude Medical · Mar 2013